Amicus Therapeutics Executives Engage in Major Share Trades Amid Market Fluctuations

Amicus Therapeutics, Inc. has announced various transactions involving its directors and officers. Specifically, Director, President and CEO Campbell Bradley L sold 14,587 shares at $10.04 per share on November 24, 2025, and subsequently purchased the same number of shares at $9.03 per share on the same day. Chief Development Officer Jeff Castelli bought 50,000 shares at $9.03 per share on November 24, 2025, while also selling 76,158 shares at $10.16 per share on the same day. Chief People Officer David Michael Clark sold 25,643 shares at $10.1 per share on November 24, 2025. Additionally, Chief Legal Officer Ellen Rosenberg sold 23,621 shares at $10 per share on November 26, 2025, but purchased 36,000 shares at $5.13 per share on November 25, 2025, and another 11,000 shares at the same price on November 24, 2025. Rosenberg also sold 36,000 shares at $10.06 per share on November 24, 2025, and purchased 23,621 shares at $5.13 per share on November 26, 2025. Furthermore, Rosenberg sold 36,000 shares at $10 per share on November 25, 2025, and bought 25,000 shares at $6.1 per share on November 24, 2025.